To order this 250+ page report, which features 85+ figures and 125+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html

Key Market Insights
 More than 200 preventive vaccines, developed by both industry and non-industry players, are being evaluated in clinical stages of development
 A variety of vaccine APIs, designed for administration via multiple routes of delivery, are presently being investigated; most such candidates are in the early stages of development
 In order to achieve a competitive edge, vaccine developers are putting in significant efforts to ensure that their candidates are clinically and commercially competent
 Foreseeing a lucrative future in this domain, several private and public investors have invested close to USD 10 billion in vaccine development initiatives, across 170 instances, in the time period between 2015 and 2020
 Over the last few years, 1,400+ clinical trials evaluating various types of preventive vaccines have been registered, indicating the rapid pace of development in this field
 Case-in-Point: Around 70 companies, situated in different regions across the globe, claim to provide contract development, fill / finish and regulatory support, in addition to manufacturing services
 The market is anticipated to grow at a CAGR of 10.7%, till 2030, and the projected opportunity is likely to be distributed across various routes of administration, vaccine types and key geographical regions

For more information, please visit https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]